Evaluating Online Direct-to-Consumer Marketing of Genetic Tests: Informed Choices or Buyers Beware?
Authors:
- 1 March 2008
- journal article
- research article
- Published by SAGE Publications in Genetic Testing
- Vol. 12 (1) , 13-23
Abstract
Commercialization of genetic technologies is expanding the horizons for the marketing and sales of genetic tests direct-to-consumers (DTCs). This study assesses the information provision and access requirements that are in place for genetic tests that are being advertised DTC over the Internet. Sets of key words specific to DTC genetic testing were entered into popular Internet search engines to generate a list of 24 companies engaging in DTC advertising. Company requirements for physician mediation, genetic counseling arrangements, and information provision were coded to develop categories for quantitative analysis within each variable. Results showed that companies offering risk assessment and diagnostic testing were most likely to require that testing be mediated by a clinician, and to recommend physician-arranged counseling. Companies offering enhancement testing were less likely to require physician mediation of services and more likely to provide long-distance genetic counseling. DTC advertisements often provided information on disease etiology; this was most common in the case of multifactorial diseases. The majority of companies cited outside sources to support the validity of claims about clinical utility of the tests being advertised; companies offering risk assessment tests most frequently cited all information sources. DTC advertising for genetic tests that lack independent professional oversight raises troubling questions about appropriate use and interpretation of these tests by consumers and carries implications for the standards of patient care. These implications are discussed in the context of a public healthcare system.Keywords
This publication has 22 references indexed in Scilit:
- Benefits and harms of direct to consumer advertising: a systematic reviewQuality and Safety in Health Care, 2005
- Portrayal of Genetic Risk for Breast Cancer in Ethnic and Non-Ethnic NewspapersWomen & Health, 2005
- Evaluating Direct-to-Consumer Marketing of Race-Based Pharmacogenomics: A Focus Group Study of Public Understandings of Applied Genomic MedicationJournal of Health Communication, 2004
- Public Experiences, Knowledge and Expectations about Medical Genetics and the Use of Genetic InformationPublic Health Genomics, 2004
- Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer BewareJournal of Clinical Oncology, 2003
- Direct-to-consumer sales of genetic services on the InternetGenetics in Medicine, 2003
- Genetic TestingNew England Journal of Medicine, 2002
- Limitations of Direct-to-Consumer Advertising for Clinical Genetic TestingJAMA, 2002
- Riskier Than We Think? The Relationship Between Risk Statement Completeness and Perceptions of Direct to Consumer Advertised Prescription DrugsJournal of Health Communication, 2000
- The Commercialization of Human Genetics: A Discussion of Issues Relevant to the Canadian ConsumerJournal of Consumer Policy, 1998